<?xml version="1.0" encoding="UTF-8"?>
<fig id="f3">
 <label>Figure 3</label>
 <caption>
  <title>Fatty acid synthesis requirement for CHIKV life cycle.</title>
  <p>(
   <bold>a</bold>) Impact of FASN or ACLY knockdown on CHIKV replication. Closed and open symbols indicate replicates from the primary screen and during validation, respectively. (
   <bold>b</bold>) Western blot showing silencing efficiency of siRNAs used in 
   <bold>c</bold>. (
   <bold>c</bold>) Impact of FASN-, ACC- and ACLY-specific siRNAs on CHIKV replication (
   <italic>n</italic>=10 for each data set). (
   <bold>d</bold>) Confocal section of CHIKV replicon-infected HeLa cells labelled for FASN, dsRNA and 4,6-diamidino-2-phenylindole (DAPI; blue). Scale bar, 10 μm. (
   <bold>e</bold>) Co-localization analysis of cells labelled as in 
   <bold>d</bold> and in 
   <xref ref-type="supplementary-material" rid="S1">Supplementary Fig. 3b</xref>, plotted as Pearson's coefficient per cell. Each symbol corresponds to a cell stack from three independent experiments (
   <italic>n</italic>=29 cells for FASN, 30 cells for ACC and 31 cells for ACLY); median values shown in red. (
   <bold>f</bold>) Effect of FASN (cerulenin, 
   <italic>n</italic>=12 for each data set), ACC (TOFA, 
   <italic>n</italic>=11 for each data set) and ACLY (BMS-303141 
   <italic>n</italic>=11 for each data set) inhibitors on CHIKV replication. (
   <bold>g</bold>) Real-time cell toxicity assay performed on HeLa cells (
   <italic>n</italic>=3 for each point). Excepted for 
   <bold>b</bold> and 
   <bold>d</bold> where representative images are shown and for 
   <bold>g</bold> where the mean±s.d. is shown for each point of a representative experiment, all data represent the means±s.e.m. of three independent experiments analysed using one-way analysis of variance with Tukey's post test (*
   <italic>P</italic>&lt;0.05; **
   <italic>P</italic>&lt;0.01; ***
   <italic>P</italic>&lt;0.001; 
   <sup>NS</sup>
   <italic>P</italic>≥0.05). NS, not significant.
  </p>
 </caption>
 <graphic xlink:href="ncomms11320-f3" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
